2025.06.06
Preserving cell viability and functionality during cryopreservation is critical for cell therapies, biobanking, and research reproducibility. Yet, one often overlooked factor is endotoxin contamination—a hidden threat that compromises cell health, post-thaw recovery, and downstream applications.
Kryogene’s CGT Cryopreservation Media is engineered to address this challenge head-on. With ultra-low endotoxin levels (<0.5 EU/mL), our serum-free, animal component-free formula ensures your cells remain pristine from freeze to thaw.
Why does endotoxin matter?
· High endotoxins trigger inflammatory responses, damaging cell membranes and reducing viability.
· They disrupt post-thaw functionality, skewing experimental results and jeopardizing therapeutic efficacy.
· Traditional cryoprotectants often fail to control endotoxins, risking batch inconsistencies and regulatory hurdles.
Kryogene delivers results:
· 95%+ post-thaw viability even after long-term storage (validated across CAR-T, NK, MSC, and primary cells).
· Preserved cell function: Maintain phenotype, proliferation, and differentiation potential for reliable downstream use.
· cGMP-compliant: Ideal for clinical applications, with strict quality control and batch-to-batch consistency.
Join leading labs and biotechs who trust Kryogene to safeguard their most valuable cell assets. Elevate your cryopreservation standards—because every cell counts.
